Dr. Anna Nolan, MD

Media Releases

Combining Clinical Expertise with Innovative Research to Tackle Lung Disease and Improve Patient Outcomes

New York, New York – Anna Nolan, MD, a skilled pulmonologist and physician-scientist, proudly serves as the Director of Research Oversight at NYC Health + Hospitals / Bellevue, while also treating adults at NYU Langone Pulmonary And Critical Care Associates on 41st Street. With her extensive background in pulmonary and critical care medicine, Dr. Nolan is dedicated to advancing the field through both clinical practice and groundbreaking research.

As a Professor in the Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine at NYU Grossman School of Medicine, Dr. Nolan brings a wealth of knowledge and experience to her role. She earned her Bachelor of Arts Degree in Chemistry from Barnard College in 1992 and her Medical Degree from SUNY-Downstate’s College of Medicine in 1996. Following her internal medicine residency at St. Luke’s-Roosevelt Hospital Center, she completed a fellowship in pulmonary and critical care medicine at NYU Grossman School of Medicine in 2003 and obtained her Master of Science Degree in Clinical Investigation from the same institution in 2007.

Dr. Nolan is board-certified in internal medicine, pulmonary disease, and critical care medicine, with certifications dating back to 1999, 2002, and 2003, respectively. She is a Fellow of both the American College of Chest Physicians and the American Thoracic Society, as well as a member of the Society of Critical Care Medicine.

Currently, as Principal Investigator of the Nolan Lab at NYU Langone, Dr. Nolan leads a team focused on investigating the impact of World Trade Center dust exposure on lung function using mouse models. Her research also delves into the roles of the receptor for advanced glycation end products (RAGE) and lysophosphatidic acid (LPA), a cholesterol derivative, as part of her broader interests that include COVID-19, biomarkers, and lung inflammation. 

Dr. Nolan’s innovative approach incorporates machine learning and artificial intelligence to develop prediction models aimed at understanding metabolic syndrome, cardiovascular disease, and aerodigestive conditions. Her work is crucial in examining the impact of these conditions on lung health and overall disease progression.

Fluent in English and Greek, Dr. Nolan is committed to improving health outcomes for diverse communities in New York City. Her dedication to research and patient care continues to inspire fellow clinicians and researchers alike.

Recommended Articles

• COPD Pathophysiology - How Do You Develop COPD?

  Chronic Obstructive Pulmonary Disease (COPD) is a chronic, progressive disease of the airways leading to irreversible air flow limitation. COPD encompasses two types of obstructive airway diseases:1. Chronic bronchitis – An obstruction of the airways2. Emphysema – An enlargement of air spaces...

• University Dance Promotes Cystic Fibrosis Awareness

  Cystic fibrosis is considered incurable, and is a daily struggle for all of those who have it. Constant research is being poured into finding better treatment, and potentially even a cure, but Rowan's Public Relations Student Society of America (PRSSA) is putting their own spin (literally) on...

• Bronchiolitis – Signs, Symptoms, and Treatment

  What is Bronchiolitis?Bronchiolitis is a viral infection of the respiratory system, usually affecting the smallest air passages known as the bronchioles. Bronchioles are part of the lungs that control the airflow in and out of the lungs. When these bronchioles become infected, they tend to swell and...

• Coping with COPD

  Many people live life without realizing that they have COPD – the umbrella term for emphysema and bronchitis – even though it is a common disease.Long-term smokers will most likely have scars on their lungs that will become inflamed and irritated due to COPD. Patients tend to complain, but fail...

• Helping a Child with Cystic Fibrosis Find Hope

  Cystic fibrosis is a serious and debilitating illness that is lifelong, affecting people often from infancy. What some people may not realize is how difficult it may be for children to understand what is happening to their body.Most small children with the disease have gone through more difficult...

• Cystic Fibrosis: Talking to Loved Ones

  When getting a life-changing diagnosis, it may be hard to discuss it with others. It is isolating when you feel others do not understand; your family and friends may not have cystic fibrosis or know people affected by the disease. You may also be dealing with shock from the new diagnosis. Chances...